EPG Online Twitter
EPG Online Blog
Disease Knowledge
Drug Updates
- Fostair 100/6 inhalation solution
- Epanutin capsules 25, 50 and 100mg
- Eprex 2000, 4000 and 10000 IU/ml solution for injection in pre-filled syringe
- FemSeven Conti
- Epanutin 300mg hard capsules
- Bedranol 80mg SR Capsules
- Bedranol 160mg SR Capsules
- Betim 10mg Tablets
- Carbo-Dome Cream
- Bisoprolol 2.5mg/5mg/10mg film coated tablet
- Phenergan Injection
- Rivotril 0.5 mg and 2 mgTablets
- Rivotril Ampoules
- RELPAX 20mg and 40mg Film-Coated Tablets
- Witch Doctor ® 81.5%w/w Gel
- Levetiracetam Actavis 1,000 mg film-coated tablets
- Levetiracetam Actavis 250 mg film-coated tablets
- Levetiracetam Actavis 500 mg film-coated tablets
- Levetiracetam Actavis 750 mg film-coated tablets
- Lidocaine Hydrochloride Injection BP 1% w/v plastic ampoules
- Lidocaine Hydrochloride Injection BP 2.0% w/v
- Omeprazole 10mg Capsules
- Omeprazole 20mg Capsules
- Panadol Extra Advance 500 mg/65 mg Tablets
- Allopurinol Tablets BP 300mg
- Allopurinol Tablets BP 100mg
- Anadin Ultra Double Strength 400mg Capsules/Anadin LiquiFast 400mg Capsules
- Calcipotriol Scalp Solution
- Bupivacaine Hydrochloride Injection BP 0.5% w/v.
- Lescol (fluvastatin* sodium) 20 mg and 40 mg capsules
- Meropenem 1 g Powder for Solution for Injection or Infusion
- VALTREX Tablets 250mg
- Vesicare 5mg & 10mg film-coated tablets
- Zomig 5mg Nasal Spray
- Water for Injections
- Tizanidine 2mg Tablets
- NovoRapid 100 U/ml in a vial, NovoRapid Penfill 100 U/ml, NovoRapid FlexPen 100 U/ml, NovoRapid FlexTouch 100 U/ml
- Orfadin 10 mg hard capsules
- Orfadin 2 mg hard capsules
- Natecal D3 Chewable Tablets
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
Fibrinolytics.
Alteplase
Powder in vial plus diluent.
Powder for injection, alteplase 10 mg , 20 mg , 50 mg .
Acute myocardial infarction; acute pulmonary embolism.
Total dose of 100 mg intravenously over three hours. MI: administer over 90 minutes if within 6 hours of symptom onset, over 3 hours if 6 - 12 hours. PE: administer over 2 hours. See Summary of Product Characteristics.
Not recommended.
Situations where there is a high risk of haemorrhage such as: bleeding diathesis, within 10 bleeding diathesis, within 10 days of haemorrhage or surgery, active peptic ulceration, acute pancreatitis, bacterial endocarditis, severe liver disease; history of stroke or CNS damage; severe controlled hypertension.
Situations where risk of bleeding is increased. Pregnancy. Elderly. Actilyse should be given only by physicians experienced in the use of thrombolytics and with the facilities to monitor it.
Anticoagulants.
Bleeding is the most frequent adverse reaction. This may be superficial bleeding from punctures or damaged blood vessels, or internal bleeding into the urogenital tract, retroperitoneum or CNS or bleeding of parenchymatous organs. Intracranial haemorrhage. Cholesterol crystal embolisation or thrombotic embolisation rarely. Arrhythmias associated with reperfusion may occur. Nausea, vomiting, hypotension and fever may occur rarely.
Boehringer Ingelheim
(POM)
01 May 2001
- ACTILYSE
- AGGRASTAT
- ALPHAPARIN
- ANGETTES 75
- ASASANTIN RETARD
- Aspirin (MI)
- CANUSAL
- CAPRIN (MI)
- CLIVARINE
- Clopidogrel 75 mg Film-coated Tablets
- Dipyridamole
- DISPRIN CV
- FLOLAN
- Fragmin - Treatment of VTE
- Heparin calcium 25,000 I.U./ml Solution for injection or concentrate for solution for infusion
- HEPSAL
- INTEGRILIN
- KABIKINASE





